Georg Griesemann is the founder of Clinomic. Clinomic has raised $26M in total funding. Latest round: Series B. Based in Aachen, Germany.
Georg Griesemann is the CEO of Clinomic, a medical technology company that leverages AI and data-driven solutions to enhance intensive care. Founded in 2019 by intensive care physicians, Clinomic developed the Mona platform to streamline ICU workflows by recording, analyzing, and visualizing patient and operational data. The company recently secured a €23 million Series B investment to expand into international markets and further develop its AI capabilities.
Full founder directory · Investor directory · Company funding database · Fundraising library